Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
ohm20's Profile
Displaying 751-800 of 6028 result(s).
CYDY CytoDyn Inc
05/17/2024 2:34:38 PM
OHM I’m assuming because the mech (11)
CYDY CytoDyn Inc
05/17/2024 12:41:08 AM
Cetuximab, sold under the brand nam (8)
CYDY CytoDyn Inc
05/17/2024 12:33:42 AM
Are they resurrecting this trial (N (7)
CYDY CytoDyn Inc
05/17/2024 12:07:17 AM
Good article. The bacteria in the g (7)
CYDY CytoDyn Inc
05/16/2024 11:59:32 PM
Keytruda's my guess. From the mouse (15)
CYDY CytoDyn Inc
05/16/2024 11:52:00 PM
I tis interesting that they are not (13)
CYDY CytoDyn Inc
05/16/2024 4:39:48 PM
Also there is a high CCR5 expressio (20)
CYDY CytoDyn Inc
05/15/2024 6:22:36 PM
Here is what Leqembi does - Lecanem (21)
CYDY CytoDyn Inc
05/15/2024 11:09:00 AM
There is not a lot of specific inf (7)
CYDY CytoDyn Inc
05/15/2024 12:23:20 AM
Or maybe that's just Respert, throw (3)
CYDY CytoDyn Inc
05/15/2024 12:18:36 AM
Don't we want them to have FOMO adr (2)
CYDY CytoDyn Inc
05/14/2024 2:39:06 PM
Firstrade is commission free even o (6)
CYDY CytoDyn Inc
05/13/2024 3:28:24 PM
Should such a document exist clearl (3)
CYDY CytoDyn Inc
05/12/2024 6:06:30 AM
Nor the nasty, unkind words from hi (21)
CYDY CytoDyn Inc
05/10/2024 5:38:44 AM
Assignee is actually I/O INTERCONNE (1)
CYDY CytoDyn Inc
05/10/2024 2:11:19 AM
Stupidity is clearly not illegal. I (8)
CYDY CytoDyn Inc
05/10/2024 12:50:35 AM
Something I have not seen mentioned (11)
CYDY CytoDyn Inc
05/10/2024 12:41:20 AM
but I have seen no actual evidence (7)
CYDY CytoDyn Inc
05/08/2024 1:12:56 PM
It does appear that Leronlimab is a (15)
CYDY CytoDyn Inc
05/08/2024 1:08:40 PM
The bright side is we only used Bor (5)
CYDY CytoDyn Inc
05/08/2024 1:07:43 PM
New' genetic Alzheimer's disease ma (28)
CYDY CytoDyn Inc
05/07/2024 1:05:53 AM
It is not a question of if "these g (19)
CYDY CytoDyn Inc
05/07/2024 1:00:08 AM
ohm: how reasonable would it be to (11)
CYDY CytoDyn Inc
05/06/2024 5:52:26 PM
Well, in the case of a cancer that (16)
CYDY CytoDyn Inc
05/06/2024 5:18:41 PM
There was an article in Nature on 5 (11)
CYDY CytoDyn Inc
05/01/2024 5:04:14 PM
There are no holds for any indicati (12)
CYDY CytoDyn Inc
05/01/2024 4:58:26 AM
Yes it is. (1)
CYDY CytoDyn Inc
04/29/2024 5:04:41 PM
Once we publish, maybe we'll start (6)
CYDY CytoDyn Inc
04/28/2024 1:17:05 PM
Just formation of a business minded (6)
CYDY CytoDyn Inc
04/28/2024 12:53:45 PM
Which adds to there was no risk to (14)
CYDY CytoDyn Inc
04/28/2024 12:30:52 PM
Wouldn't that be using the costs as (6)
CYDY CytoDyn Inc
04/28/2024 12:27:45 PM
If leronlimab was absorbable via th (5)
CYDY CytoDyn Inc
04/28/2024 12:14:57 PM
Also forgot Musk demolished the dea (16)
CYDY CytoDyn Inc
04/28/2024 11:58:02 AM
Personally, I choose to believe, tr (8)
CYDY CytoDyn Inc
04/28/2024 11:40:19 AM
Far as I know, maybe nieve, doctors (6)
CYDY CytoDyn Inc
04/25/2024 11:42:10 PM
Don't know IF we've seen this.. ohm (3)
CYDY CytoDyn Inc
04/24/2024 6:41:35 AM
In another, earlier study of metast (25)
CYDY CytoDyn Inc
04/22/2024 10:16:25 AM
who is listed as a sender in what e (5)
CYDY CytoDyn Inc
04/22/2024 10:10:45 AM
it would be nice to screen for muta (6)
CYDY CytoDyn Inc
04/22/2024 10:05:19 AM
I have looked at LL’s HIV trials, (16)
CYDY CytoDyn Inc
04/20/2024 12:40:59 PM
We also got shanked on the mild mod (6)
CYDY CytoDyn Inc
04/20/2024 12:34:02 PM
The money needed to buy the shares (8)
CYDY CytoDyn Inc
04/19/2024 5:19:10 AM
So just aww heck, let's get this li (5)
CYDY CytoDyn Inc
04/19/2024 1:43:33 AM
Chris Sandburg was a pen name for a (5)
CYDY CytoDyn Inc
04/19/2024 1:24:59 AM
Here's a few more docs released on (12)
CYDY CytoDyn Inc
04/18/2024 4:45:46 PM
i think the FDA's explanation or ba (24)
CYDY CytoDyn Inc
04/18/2024 12:09:16 AM
To your point, China has a longer a (6)
CYDY CytoDyn Inc
04/17/2024 7:45:32 AM
We cannot beat China on manufacturi (17)
CYDY CytoDyn Inc
04/17/2024 12:19:13 AM
I thought the era of McCarthyism wa (11)
CYDY CytoDyn Inc
04/15/2024 6:00:37 PM
it seems that at the bare minimum, (8)
Go to page:
  • << First
  • < Previous
  • 15
  • 16
  • Next >

Recent Articles

  • Kering's Monthly Share and Voting Rights Breakdown for 2025
  • Exploring Altus Group's Latest Insights on European CRE Trends
  • Disney Shifts Marvel Productions from Georgia to UK for Savings
  • Riders Prefer Waymo Robotaxis Over Uber Drivers in Atlanta
  • GigaCloud Technology Launches $111 Million Share Repurchase Initiative
  • GigaCloud Technology Welcomes Kerry Lebensburger to Board
  • Manipal Hospitals Expands Cancer Care with Dr. Dabas' Expertise
  • Enhanced Shareholder Benefits from 180 Degree and Mount Logan Merger
  • E-bike Market Expected to Reach $87.2 Billion Through Innovation
  • Breakthrough Therapy Designation for Izalontamab Brengitecan
  • Heineken N.V. Shares Progress on Major Buyback Initiatives
  • Celebrating a Decade of Innovation: IDEAYA Biosciences R&D Day
  • Heineken Holding N.V. Shares Buyback Program Update and Details
  • KuCoin Pay and Umy Revolutionizing Travel Payments with Crypto
  • KuCoin Pay Teams Up with Umy to Enhance Travel with Crypto
  • Yuchai Delivers Natural Gas Buses, Enhancing Public Transport
  • Echosens and Novo Nordisk Collaborate to Enhance MASH Awareness
  • Air Canada Navigates Challenges with Suspended Guidance for 2025
  • Revolutionizing Wealth Management with Agentic AI Technology
  • Three Sticks Wines Achieves Excellence in Recent Awards
  • Metal Supermarkets Awards Scholarships to Future Trades Experts
  • CaringKind Welcomes Dr. Kendra Ray as Chief Research Officer
  • Innovative Merger Transforms Indoor Farming Landscape
  • Supporting Michigan Families: Consumers Energy's Latest Initiative
  • Rubenstein Law's Megan Schmidt Joins Esteemed Leadership Program
  • Transforming Climate Control: The Rise of Smart HVAC Solutions
  • Understanding Consumer Credit Trends Amid Economic Challenges
  • Airsed Securities Launches Innovative Trading Platform for Investors
  • Exciting Trading Opportunities with XXKK Exchange's Bonus Offer
  • Kering Reports August 2025 Shareholder Voting Details
  • Opportunities for Sarepta Therapeutics Investors Amid Lawsuit
  • Understanding Caisse Française de Financement Local's Asset Quality Insights
  • Stock Futures Slip as Market Anticipates Earnings Reports
  • Strengthening Cancer Care: Dr. Dabas Joins Manipal Hospitals
  • Understanding the Impacts of a Steepening Yield Curve
  • Emini Futures Reach New Heights in September Trading Surge
  • Earnings Season Insights: Key Trends and Market Movements
  • Natural Language Understanding Market Growth and Trends Ahead
  • Sisecam Reports Strong Financial Performance with 101 Billion TL Sales
  • Understanding Disclosure Trends with AXA Investment Managers
  • New Class Action Lawsuit Presented by Schall Law Firm for RxSight
  • RxSight, Inc. Under Investigation: What You Need to Know
  • Sisecam Achieves Remarkable Sales Growth with 101 Billion TL
  • Fibank Secures €50 Million Bond Placement to Boost Stability
  • Fibank's Innovative €50 Million Bond Issue Boosts Growth Plans
  • Caisse Française de Financement Local Publishes Quality Report
  • Solo Bitcoin Miner Celebrates Windfall of Over $360,000
  • Boliden Addresses Changes in Finnish Mining Tax Proposals
  • Market Dynamics: Easing Strategies and the Role of Technology
  • Kandi Technologies Partners with CATL for Battery Swap Stations
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site